4E-BP2 can limit the anti-inflammatory response of macrophages by inhibiting IL-10 and cyclooxygenase-2 (65), and the activation of p70 S6K can reduce skin inflammation in atopic dermatitis (66). Here, RPS6KB1 is linked to atopic eczema.